CNIO Arte en ARCO 2024 CNIO Arte 2024 Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Inicio | Eventos | Analysis of genetic ablation of mutant Kras versus its inhibition in lung adenocarcinoma

Analysis of genetic ablation of mutant Kras versus its inhibition in lung adenocarcinoma

Información

Fecha: 14/07/2022
Hora 11:00
Lugar: Auditorio CNIO y online
Conferenciante Marina Salmón
Procedencia Experimental Oncology Group, Molecular Oncology Programme
Supervised by Mariano Barbacid and Matthias Drosten, Experimental Oncology Group, Molecular Oncology Programme
Entrada libre hasta completar aforo

Subir